Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor agents isolated from fungal strains by Roche

March 6, 1998

PKC antisense oligonucleotide shows promise in cancer therapy

March 6, 1998

Purdue discloses antitumor selenophene compounds

March 5, 1998

Colchicine analogues from Indena show potential for resistant tumors

March 5, 1998

Chemopotentiating agents in R&D at Nippon Flour Milling

March 5, 1998

Gliadel Wafer approved for marketing in Brazil

March 4, 1998

BOPP will enter clinical testing in cancer patients

March 4, 1998

Searle uses Epimmune technologies to develop cancer therapies

March 4, 1998

Status of Oncolym updated

March 4, 1998

Select Therapeutics licenses cancer-related technology

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...